Patients CinCor Pharma: A small pharma’s journey to acquisition In this week's podcast, pharmaphorum welcomes Marc de Garidel, CEO of CinCor Pharma.
News AZ cancer drugs chalk up wins in early-stage lung cancer Tagrisso and Imfinzi show benefit as neoadjuvant and adjuvant therapy for patients with NSLC.
News Daiichi Sankyo wins round in Enhertu patent dispute US PTO has agreed to take another look at whether Seagen's '039 patent is valid.
News Lynparza under siege in first-line prostate cancer New data from Pfizer and J&J encroach on AZ and Merck's territory with the PARP inhibitor.
News NICE won’t back AZ’s Evusheld for COVID prevention Blood Cancer UK calls for help for the 'forgotten 500,000' who can't be protected with vaccines
News 5 reasons AZ may be siting its new plant in Ireland, not UK AstraZeneca's revelation in its fourth-quarter results update - that it had decided to build a new $360 million manufacturing facility in Ireland, rather than its home ter
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
